22642825|t|Tumor necrosis factor-alpha synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease.
22642825|a|BACKGROUND: Neuroinflammation is associated with virtually all major neurodegenerative disorders, including Alzheimer's disease (AD). Although it remains unclear whether neuroinflammation is the driving force behind these disorders, compelling evidence implicates its role in exacerbating disease progression, with a key player being the potent proinflammatory cytokine TNF-alpha. Elevated TNF-alpha levels are commonly detected in the clinic and animal models of AD. METHODS: The potential benefits of a novel TNF-alpha-lowering agent, 3,6'-dithiothalidomide, were investigated in cellular and rodent models of neuroinflammation with a specific focus on AD. These included central and systemic inflammation induced by lipopolysaccharide (LPS) and Abeta(1-42) challenge, and biochemical and behavioral assessment of 3xTg-AD mice following chronic 3,6'-dithiothaliodmide. RESULTS: 3,6'-Dithiothaliodmide lowered TNF-alpha, nitrite (an indicator of oxidative damage) and secreted amyloid precursor protein (sAPP) levels in LPS-activated macrophage-like cells (RAW 264.7 cells). This translated into reduced central and systemic TNF-alpha production in acute LPS-challenged rats, and to a reduction of neuroinflammatory markers and restoration of neuronal plasticity following chronic central challenge of LPS. In mice centrally challenged with A(beta1-42) peptide, prior systemic 3,6'-dithiothalidomide suppressed Abeta-induced memory dysfunction, microglial activation and neuronal degeneration. Chronic 3,6'-dithiothalidomide administration to an elderly symptomatic cohort of 3xTg-AD mice reduced multiple hallmark features of AD, including phosphorylated tau protein, APP, Abeta peptide and Abeta-plaque number along with deficits in memory function to levels present in younger adult cognitively unimpaired 3xTg-AD mice. Levels of the synaptic proteins, SNAP25 and synaptophysin, were found to be elevated in older symptomatic drug-treated 3xTg-AD mice compared to vehicle-treated ones, indicative of a preservation of synaptic function during drug treatment. CONCLUSIONS: Our data suggest a strong beneficial effect of 3,6'-dithiothalidomide in the setting of neuroinflammation and AD, supporting a role for neuroinflammation and TNF-alpha in disease progression and their targeting as a means of clinical management.
22642825	0	27	Tumor necrosis factor-alpha	Gene	21926
22642825	48	70	3,6'-dithiothalidomide	Chemical	MESH:C562075
22642825	93	105	inflammation	Disease	MESH:D007249
22642825	107	116	Alzheimer	Disease	MESH:D000544
22642825	142	150	deficits	Disease	MESH:D009461
22642825	171	188	neuroinflammation	Disease	MESH:D000090862
22642825	193	212	Alzheimer's disease	Disease	MESH:D000544
22642825	226	243	Neuroinflammation	Disease	MESH:D000090862
22642825	283	310	neurodegenerative disorders	Disease	MESH:D019636
22642825	322	341	Alzheimer's disease	Disease	MESH:D000544
22642825	343	345	AD	Disease	MESH:D000544
22642825	384	401	neuroinflammation	Disease	MESH:D000090862
22642825	559	574	proinflammatory	Disease	
22642825	584	593	TNF-alpha	Gene	21926
22642825	604	613	TNF-alpha	Gene	21926
22642825	678	680	AD	Disease	MESH:D000544
22642825	725	734	TNF-alpha	Gene	21926
22642825	751	773	3,6'-dithiothalidomide	Chemical	MESH:C562075
22642825	826	843	neuroinflammation	Disease	MESH:D000090862
22642825	869	871	AD	Disease	MESH:D000544
22642825	909	921	inflammation	Disease	MESH:D007249
22642825	933	951	lipopolysaccharide	Chemical	MESH:D008070
22642825	953	956	LPS	Chemical	MESH:D008070
22642825	1030	1037	3xTg-AD	CellLine	CVCL:RN76
22642825	1038	1042	mice	Species	10090
22642825	1061	1083	3,6'-dithiothaliodmide	Chemical	-
22642825	1094	1116	3,6'-Dithiothaliodmide	Chemical	-
22642825	1125	1134	TNF-alpha	Gene	21926
22642825	1136	1143	nitrite	Chemical	MESH:D009573
22642825	1235	1238	LPS	Chemical	MESH:D008070
22642825	1272	1281	RAW 264.7	CellLine	CVCL:0493
22642825	1340	1349	TNF-alpha	Gene	24835
22642825	1370	1373	LPS	Chemical	MESH:D008070
22642825	1385	1389	rats	Species	10116
22642825	1413	1430	neuroinflammatory	Disease	MESH:D000090862
22642825	1517	1520	LPS	Chemical	MESH:D008070
22642825	1525	1529	mice	Species	10090
22642825	1592	1614	3,6'-dithiothalidomide	Chemical	MESH:C562075
22642825	1626	1631	Abeta	Gene	11820
22642825	1640	1658	memory dysfunction	Disease	MESH:D008569
22642825	1686	1707	neuronal degeneration	Disease	MESH:D009410
22642825	1717	1739	3,6'-dithiothalidomide	Chemical	MESH:C562075
22642825	1791	1798	3xTg-AD	CellLine	CVCL:RN76
22642825	1799	1803	mice	Species	10090
22642825	1842	1844	AD	Disease	MESH:D000544
22642825	1889	1894	Abeta	Gene	11820
22642825	1907	1912	Abeta	Gene	11820
22642825	1938	1946	deficits	Disease	MESH:D009461
22642825	2024	2031	3xTg-AD	CellLine	CVCL:RN76
22642825	2032	2036	mice	Species	10090
22642825	2071	2077	SNAP25	Gene	20614
22642825	2082	2095	synaptophysin	Gene	20977
22642825	2157	2164	3xTg-AD	CellLine	CVCL:RN76
22642825	2165	2169	mice	Species	10090
22642825	2337	2359	3,6'-dithiothalidomide	Chemical	MESH:C562075
22642825	2378	2395	neuroinflammation	Disease	MESH:D000090862
22642825	2400	2402	AD	Disease	MESH:D000544
22642825	2426	2443	neuroinflammation	Disease	MESH:D000090862
22642825	2448	2457	TNF-alpha	Gene	21926
22642825	Positive_Correlation	MESH:D008070	MESH:D007249
22642825	Negative_Correlation	MESH:C562075	MESH:D000544
22642825	Negative_Correlation	MESH:C562075	MESH:D000090862
22642825	Negative_Correlation	MESH:C562075	21926
22642825	Negative_Correlation	MESH:C562075	MESH:D009461
22642825	Positive_Correlation	MESH:D009410	11820
22642825	Negative_Correlation	MESH:C562075	MESH:D009410
22642825	Negative_Correlation	MESH:C562075	MESH:D008569
22642825	Negative_Correlation	MESH:C562075	11820
22642825	Positive_Correlation	MESH:D000544	21926
22642825	Positive_Correlation	MESH:D008569	11820
22642825	Positive_Correlation	MESH:D008070	24835
22642825	Negative_Correlation	MESH:C562075	MESH:D007249

